Highlights
NASDAQ: DMPI       Delmar Pharmaceuticals Inc
Last Price Today's Change   Day's Range   Trading Volume
0.755   -0.059 (7.25%)  0.72 - 0.854  973,804

Overview

 
Avg Volume (4 weeks):711,645
4 Weeks Range:0.445 - 0.86
4 Weeks Price Volatility (%):
74.70%
52 Weeks Range:0.281 - 5.75
52 Weeks Price Volatility (%):
8.67%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

DelMar Pharmaceuticals Inc is a clinical and commercial stage drug development company, which focuses on the research and development of drugs for the treatment of cancer. The company's principal product candidate includes VAL-083, a small-molecule chemotherapeutic agent, which is in clinical trials stage for the treatment of refractory glioblastoma multiforme, a form of brain cancer. DelMar also has a strategic collaboration with Guangxi Wuzhou Pharmaceutical for the development of VAL-083 used in treating chronic myelogenous leukemia and lung cancer. All the business activity of the firm is functioned through the region of Canada.

  Be the first to like this.
 


 

2936  2597  425  3019 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 FCEL 0.887+0.077 
 CHK 0.692-0.01 
 AMD 38.43+0.91 
 CSCO 44.703-3.757 
 AABA 19.630.00 
 CPE 4.30-0.16 
 SNNA 0.316+0.156 
 NOK 3.355-0.115 
 NIO 1.753-0.147 
 AMRN 21.490.00 
Partners & Brokers